The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 51.78
Bid: 51.82
Ask: 51.86
Change: 0.44 (0.86%)
Spread: 0.04 (0.077%)
Open: 50.26
High: 53.20
Low: 49.62
Prev. Close: 51.34
LLOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Indicative results of non US tender offer

23 Jun 2017 10:01

RNS Number : 0039J
Lloyds Banking Group PLC
23 June 2017
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION IN RELATION TO THE LLOYDS BANK PLC DEBT SECURITIES DESCRIBED HEREIN AND IS DISCLOSED IN ACCORDANCE WITH THE MARKET ABUSE REGULATION.

 

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS) (THE "UNITED STATES") OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS DOCUMENT.

 

LLOYDS BANK PLC ANNOUNCES INDICATIVE RESULTS OF ITS TENDER OFFERS IN RELATION TO CERTAIN STERLING AND EURO NOTES

23 June 2017

Further to its announcement on 12 June 2017, Lloyds Bank plc (the "Offeror") is today announcing, on a non-binding basis, indicative results of its invitations to all Holders of the Notes set out in the table below to tender their outstanding Notes for purchase by the Offeror for cash up to a maximum aggregate nominal amount to be determined by the Offeror in its sole and absolute discretion (being the Maximum Acceptance Amount) (each such invitation an "Offer" and, together, the "Offers").

The Offers were announced on 12 June 2017 and were made subject to the offer and distribution restrictions set out in the tender offer memorandum dated 12 June 2017 (the "Tender Offer Memorandum"). Capitalised terms not otherwise defined in this announcement have the same meaning as assigned to them in the Tender Offer Memorandum.

INDICATIVE RESULTS

The Offeror hereby announces its non-binding intention to accept valid tenders of the Notes pursuant to the Offers with an indicative Maximum Acceptance Amount of approximately £950,273,348.

 

The following table sets out the aggregate nominal amount of Notes validly tendered pursuant to the relevant Offer, the indicative Pro-ration Factor (if any) and the indicative Series Acceptance Amount, in each case in relation to each Series of Notes.

Title of Security

ISIN Number

Nominal Amount Validly Tendered

Indicative Pro-ration Factor

Indicative Series Acceptance Amount

Indicative Series Acceptance Amount (Sterling equivalent converted at the Euro FX Rate)

Sterling Notes

£250,000,000 2.500 per cent. Notes due June 2022

XS1239389684

£80,855,000

1

£80,855,000

n.a.

Euro Notes

€1,350,000,000 Floating Rate Notes due September 2019

XS1109333986

€324,329,000

1

€324,329,000

£285,827,972

€1,000,000,000 0.625 per cent. Notes due April 2020

XS1219428957

€196,225,000

1

€196,225,000

£172,931,171

€1,500,000,000 1.000 per cent. Notes due November 2021

XS1139091372

€434,789,000

0

€0

£0

€1,250,000,000 1.375 per cent. Notes due September 2022

XS1280783983

€298,364,000

1

€298,364,000

£262,945,272

€1,250,000,000 1.250 per cent. Notes due January 2025

XS1167204699

€167,611,000

1

€167,611,000

£147,713,933

 

PRICE DETERMINATION TIME

The Price Determination Time is expected to be at or around 2.00 p.m. London time on 23 June 2017.

 

As soon as reasonably practicable after the Price Determination Time, the Offeror is expected to announce whether it will accept valid tenders of Notes of any Series pursuant to the relevant Offer and, if so, (i) the Maximum Acceptance Amount, (ii) in relation to each Series of Notes, the Series Acceptance Amount and any Pro-ration Factor(s) and (iii) the relevant Reference Yield, Repurchase Yield and Purchase Price in relation to each relevant Series of Fixed Spread Notes accepted for purchase.

 

Holders who do not participate in the Offers or whose Notes are not accepted for purchase will continue to hold their Notes subject to their terms and conditions.

 

SETTLEMENT DATE

The Settlement Date is expected to be 27 June 2017.

 

FURTHER INFORMATION

For further information please contact:

 

Investor Relations:

Douglas Radcliffe

Group Investor Relations Director

Telephone: +44 (0)20 7356 1571

Email: douglas.radcliffe@finance.lloydsbanking.com

 

 

Requests for information in relation to the Offers should be directed to:

DEALER MANAGER

Lloyds Bank plc10 Gresham StreetLondon EC2V 7AEUnited KingdomTel: +44 20 7158 2720Attention: Liability Management Groupemail: liability.management@lloydsbanking.com

Requests for information in relation to, and for any documents or materials relating to, the Offers should be directed to:

TENDER AGENT

Lucid Issuer Services LimitedTankerton Works12 Argyle WalkLondon WC1H 8HAUnited KingdomTel: +44 20 7704 0880Attention: Paul Kamminga/Arlind Bytyqiemail: lloydsbank@lucid-is.com

 

 

The Offeror launched, contemporaneously with the launch of the Offers, offers to holders of three series of U.S. dollar denominated notes issued by the Offeror. This announcement does not relate to the U.S. Offer.

DISCLAIMER

This announcement must be read in conjunction with the announcement relating to the Offers published via RNS on 12 June 2017 and the Tender Offer Memorandum. This announcement does not constitute an offer or an invitation to participate in the Offers in the United States or in any other jurisdiction in which, or to any person to or from whom, it is unlawful to make such offer or invitation or for there to be such participation under applicable laws.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUOVWRBNANURR
Date   Source Headline
24th Apr 20246:21 pmRNSTransaction in Own Shares
24th Apr 20242:37 pmRNSPublication of Suppl.Prospcts
24th Apr 202412:29 pmRNSPublication of Suppl.Prospcts
24th Apr 202411:03 amRNS2024 Q1 Interim Management Statement
24th Apr 20247:00 amRNS2024 Q1 Interim Management Statement
23rd Apr 20246:05 pmRNSTransaction in Own Shares
22nd Apr 20245:55 pmRNSTransaction in Own Shares
19th Apr 20245:41 pmRNSTransaction in Own Shares
18th Apr 20246:01 pmRNSTransaction in Own Shares
17th Apr 20246:10 pmRNSTransaction in Own Shares
16th Apr 20246:11 pmRNSTransaction in Own Shares
15th Apr 20245:59 pmRNSTransaction in Own Shares
12th Apr 20245:57 pmRNSTransaction in Own Shares
11th Apr 20245:37 pmRNSTransaction in Own Shares
11th Apr 20242:00 pmRNSDirector/PDMR Shareholding
10th Apr 20246:02 pmRNSTransaction in Own Shares
9th Apr 20246:07 pmRNSTransaction in Own Shares
8th Apr 20246:02 pmRNSTransaction in Own Shares
4th Apr 20246:05 pmRNSTransaction in Own Shares
4th Apr 202410:10 amRNSPublication of Final Terms
3rd Apr 20246:01 pmRNSTransaction in Own Shares
2nd Apr 20245:56 pmRNSTransaction in Own Shares
28th Mar 20245:46 pmRNSTransaction in Own Shares
28th Mar 20245:39 pmRNSTotal Voting Rights
28th Mar 20245:24 pmRNSPublication of a Prospectus
28th Mar 20249:30 amRNSBlock Listing of Shares
27th Mar 20246:10 pmRNSTransaction in Own Shares
26th Mar 20245:53 pmRNSTransaction in Own Shares
26th Mar 20242:00 pmRNSDirector/PDMR Shareholding
25th Mar 20245:34 pmRNSTransaction in Own Shares
22nd Mar 20246:14 pmRNSPublication of a Prospectus
21st Mar 20246:13 pmRNSTransaction in Own Shares
21st Mar 20244:28 pmRNSNotice of AGM
20th Mar 20246:16 pmRNSTransaction in Own Shares
19th Mar 20246:18 pmRNSTransaction in Own Shares
18th Mar 20246:19 pmRNSTransaction in Own Shares
15th Mar 20246:05 pmRNSTransaction in Own Shares
15th Mar 20242:00 pmRNSDirector/PDMR Shareholding
14th Mar 20245:58 pmRNSTransaction in Own Shares
13th Mar 20246:23 pmRNSTransaction in Own Shares
13th Mar 20243:00 pmRNSDirector/PDMR Shareholding
12th Mar 20246:16 pmRNSTransaction in Own Shares
11th Mar 20246:16 pmRNSTransaction in Own Shares
8th Mar 20245:33 pmRNSTransaction in Own Shares
8th Mar 20241:30 pmRNSDirector/PDMR Shareholding
7th Mar 20246:06 pmRNSTransaction in Own Shares
7th Mar 20242:29 pmRNSDirector/PDMR Shareholding
6th Mar 20246:08 pmRNSTransaction in Own Shares
6th Mar 20245:55 pmRNSHolding(s) in Company
6th Mar 20245:47 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.